Companies Investors People

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Corundum Systems Biology

Corundum Systems Biology

Corundum Systems Biology: Pioneering business development in the microbiome field.

: 14
: 2020
: ward area of Tokyo, Tokyo, JP

Corundum Systems Biology was founded with the core mission of advancing the microbiome field through innovative business development. The company focuses on creating and nurturing new ventures that leverage microbiome research to develop cutting-edge products and services. Their market focus spans across healthcare, agriculture, and environmental sectors, aiming to harness the power of microbiomes to improve human health, enhance agricultural productivity, and promote environmental sustainability.

Notable affiliated individuals and investors include leading experts in microbiome research and biotechnology investment firms. Corundum Systems Biology has achieved significant milestones, including successful partnerships with academic institutions and industry leaders, as well as the commercialization of several microbiome-based solutions. Their impact is evident in the advancement of microbiome science and its practical applications, contributing to a better understanding and utilization of microbial ecosystems for societal benefit.

Similar Companies

Petri Bio

petribio.com

Vulcan Biologics

Arcadia Science

arcadiascience.com

MarvelBiome

marvelbiome.com

MatriSys Bioscience

matrisysbio.com

Luca Biologics

BiomeSense

biomesense.com

Vedanta Biosciences

vedantabio.com

Solarea Bio

solareabio.com

DermBiont

dermbiont.com

GenieBiome

geniebiome.com

Selva

Notitia Biotechnologies

notitiabio.com

BlueTurtleBio Technologies

blueturtlebio.com

InVivo Biosystems

Quick Facts

Who are Corundum Systems Biology's competitors?

Companies similar to Corundum Systems Biology include Petri Bio, Vulcan Biologics, Arcadia Science and MarvelBiome.

When was Corundum Systems Biology founded?

Corundum Systems Biology was founded in 2020.

Where is Corundum Systems Biology's headquarters located?

Corundum Systems Biology's headquarters is located in ward area of Tokyo, Tokyo, JP.

How many employees does Corundum Systems Biology have?

Corundum Systems Biology has 14 employees as of Feb 10, 2024.

Classification

Industry: Professional Service Companies
Ownership: Venture-backed
Technology: Biotech
Geographic Exposure: Global

Customer: Enterprise
Main Product: Business Development

Tags: Biotech
Consulting